CT News and Research

RSS

Blood flow simulation tools can test and optimize Berlin Heart design

Structural and mechanical engineers at the University of California, San Diego, are working together to create blood flow simulations that could lead to improvements in the design of a cardiac pump for children born with heart defects. They hope that the design changes will improve young patients' outcomes.

11 Sep 2012

Kaleida Health's Gates Vascular Institute installs Vantage Titan 3T MR system from Toshiba

Providing patient-friendly 3T MR imaging with outstanding image quality, Kaleida Health's Gates Vascular Institute (GVI) in Buffalo, N.Y., installed the Vantage Titan 3T MR system from Toshiba America Medical Systems, Inc., the 1,400th Vantage MR installation worldwide.

11 Sep 2012

Concussion: an interview with Dr Rob Reid

Concussion happens when something produces a concussive force to the head, such as a blow to the head. The definition from the 2008 consensus, which was in Zurich, is, “concussion is defined as a complex pathophysiological process affecting the brain, induced by traumatic biomechanical forces.”

10 Sep 2012

AMAG receives Swiss marketing authorization for ferumoxytol to treat iron deficiency anemia

AMAG Pharmaceuticals, Inc. today announced that the Swiss Agency for Therapeutic Products (Swissmedic) has granted marketing authorization in Switzerland for ferumoxytol, an intravenous (IV) iron therapy to treat iron deficiency anemia (IDA) in adult patients with chronic kidney disease.

6 Sep 2012

F-18-FDG PET/CT may easily predict disease-free survival for invasive ductal breast cancer patients

Disease-free survival for invasive ductal breast cancer (IDC) patients may be easier to predict with the help of F-18-fludeoxyglucose positron emission tomography (PET)/computed tomography (CT) scans, according to research published in the September issue of The Journal of Nuclear Medicine. New data show that high maximum standard uptake value (SUVmax) of F-18-FDG in the lymph nodes prior to treatment could be an independent indicator of disease recurrence.

6 Sep 2012

European regulators approve Surefire Infusion System for chemo- and radioembolization procedures

European regulators have approved Surefire Medical's Surefire Infusion System, a next generation device for chemo- and radioembolization procedures. The Colorado-based medical device company today announced that it is launching this product in the European market immediately.

5 Sep 2012

Smoker's pack-years, age and area of emphysema are strong predictors of mortality in COPD

Identifying an individual's the smoking history could help doctors to predict survival time in people with COPD.

5 Sep 2012

Regional PACS networks may be useful in reducing cost and radiation exposure associated with trauma

According to a study in the Sept. issue of the Journal of the American College of Radiology, using a combination of the Internet and compact discs (CD) to transfer images during inter-hospital transfer is associated with much lower repeat imaging rates, suggesting that regional PACS networks may be useful for reducing cost and radiation exposure associated with trauma.

4 Sep 2012

$Noninvasive fractional flow reserve still out of reach$

Noninvasive fractional flow reserve still out of reach

A novel, noninvasive approach to determining fractional flow reserve failed to show sufficient diagnostic accuracy to meet the primary endpoint of the DeFACTO trial, but was more accurate for diagnosing coronary artery ischemia than computed tomography, reported the trial’s lead investigator.

3 Sep 2012

VIDA releases Apollo 1.2 SaaS for endobronchial emphysema treatment

VIDA Diagnostics, a leading developer of quantitative imaging analysis software for the diagnosis and treatment planning of major pulmonary disease, announced today the release and commercial availability of Apollo 1.2, here at the European Respiratory Society (ERS) meeting in Vienna, Austria.

3 Sep 2012

CT scan appears to predict risk of chronic obstructive pulmonary disease exacerbations

The respective size of two major arteries, visible on a simple computed tomography, or CT, scan, is a strong predictor of the risk of exacerbation of chronic obstructive pulmonary disease, according to new research from the University of Alabama at Birmingham published online Sept. 3, 2012, in the New England Journal of Medicine.

3 Sep 2012

Boehringer Ingelheim announces data from olodaterol plus tiotropium Phase II COPD study

Boehringer Ingelheim presented today for the first time data from a Phase II dose ranging study investigationg the combination of olodaterol, an investigational long-acting beta2-agonist (LABA), and tiotropium, a long-acting muscarinic antagonist (LAMA), in COPD patients, compared to the investigational agent olodaterol alone.

3 Sep 2012

First data from Boehringer Ingelheim’s Respimat Phase III asthma program

Boehringer Ingelheim presented today the first data from the Phase III UniTinA-asthma program. In two studies, presented at the 2012 European Respiratory Society (ERS) Congress in Vienna, Austria, tiotropium delivered once daily via the Respimat inhaler significantly improved lung function and reduced asthma exacerbations in patients who remained symptomatic on current treatment with at least high dose inhaled corticosteroids (ICS) and long-acting beta agonists (LABA).

3 Sep 2012

DNA synthesis in the 3’ and 5’ direction possible using new template-directed method

When a cell divides, it passes on genetic information by producing copies of its DNA. Chemists have also learned to copy DNA. In the journal Angewandte Chemie, a German team has now introduced a new copying technique that uses a single strand of DNA as the “master copy”, like a cell, but does not require enzymes.

30 Aug 2012

Fractional flow reserve CT shows potential to non-invasively identify coronary artery disease

A study published in the most recent issue of the Journal of the American Medical Association (JAMA) presented encouraging news regarding physicians' ability to determine blood flow and associated coronary artery disease (CAD) using noninvasive CT scanning technology.

30 Aug 2012

Carnegie Hill Radiology in New York installs Aquilion PRIME 160 series from Toshiba

Patients with irregular heartbeats (arrhythmia) are difficult to image with CT. Addressing this challenge, Carnegie Hill Radiology in New York installed the Aquilion PRIME 160 series from Toshiba America Medical Systems, Inc., featuring SURECardio Prospective software that automatically adjusts for irregular heartbeats, providing quicker, more accurate exams.

30 Aug 2012

FISH assay identifies only few lung cancer patients who could benefit from crizotinib

Break apart a couple worm-like chromosomes and they may reconnect with mismatched tips and tails - such is the case of the EML4-ALK fusion gene that creates 2-7 percent of lung cancers. Almost exactly a year ago, the FDA approved the drug crizotinib to treat these ALK+ lung cancer patients, who were likely never smokers. Informed doctors use the test called a FISH assay to check for the EML4-ALK fusion gene, and then if the test is positive, ALK+ patients benefit greatly from crizotinib.

29 Aug 2012

Catheter ablation for Afib is safe and suppresses arrhythmia recurrences

Catheter ablation for atrial fibrillation (Afib) is safe and suppresses arrhythmia recurrences in 74% of patients after a single procedure, according to results from the one-year follow-up of the Atrial Fibrillation Ablation Pilot Study, the first European registry to evaluate the real-life epidemiology of catheter ablation for AFib.

29 Aug 2012

Ultra-fast 320-detector CT scanner can accurately diagnose arterial blockages

An ultra-fast, 320-detector computed tomography (CT) scanner can accurately sort out which people with chest pain need - or don't need - an invasive procedure such as cardiac angioplasty or bypass surgery to restore blood flow to the heart, according to an international study. Results of the study, which involved 381 patients at 16 hospitals in eight countries, are scheduled to be presented at the European Society of Cardiology Congress in Munich, Germany, on August 28.

29 Aug 2012

Addition of CTP to CT angiography allows clinicians to identify flow-limiting coronary artery disease

A non-invasive imaging strategy which integrates non-invasive CT angiography (CTA) and CT myocardial perfusion imaging (CTP) has robust diagnostic accuracy for identifying patients with flow-limiting coronary artery disease in need of myocardial revascularisation, according to results of the CORE320 study presented here today by Dr Joao AC Lima from Johns Hopkins Hospital, Baltimore, USA.

29 Aug 2012

CT News and Research

Blood flow simulation tools can test and optimize Berlin Heart design

Kaleida Health's Gates Vascular Institute installs Vantage Titan 3T MR system from Toshiba

Concussion: an interview with Dr Rob Reid

AMAG receives Swiss marketing authorization for ferumoxytol to treat iron deficiency anemia

F-18-FDG PET/CT may easily predict disease-free survival for invasive ductal breast cancer patients

European regulators approve Surefire Infusion System for chemo- and radioembolization procedures

Smoker's pack-years, age and area of emphysema are strong predictors of mortality in COPD

Regional PACS networks may be useful in reducing cost and radiation exposure associated with trauma

Noninvasive fractional flow reserve still out of reach

VIDA releases Apollo 1.2 SaaS for endobronchial emphysema treatment

CT scan appears to predict risk of chronic obstructive pulmonary disease exacerbations

Boehringer Ingelheim announces data from olodaterol plus tiotropium Phase II COPD study

First data from Boehringer Ingelheim’s Respimat Phase III asthma program

DNA synthesis in the 3’ and 5’ direction possible using new template-directed method

Fractional flow reserve CT shows potential to non-invasively identify coronary artery disease

Carnegie Hill Radiology in New York installs Aquilion PRIME 160 series from Toshiba

FISH assay identifies only few lung cancer patients who could benefit from crizotinib

Catheter ablation for Afib is safe and suppresses arrhythmia recurrences

Ultra-fast 320-detector CT scanner can accurately diagnose arterial blockages

Addition of CTP to CT angiography allows clinicians to identify flow-limiting coronary artery disease

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News